Clinical Trials Browser

Phase 2 × Liver Neoplasms × lenvatinib × Clear all

NCT05532319 2025-12-30

FRONT-1

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05185739 2024-12-06

PRIMER-1

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05171335 2022-09-21

Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients

Phase 2 Enrolling by invitation

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms